List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 520 studies with search of: "Macular Degeneration"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Lucentis for Age-Related Macular Degeneration Pigment Epithelial Detachments
Conditions: Age-Related Macular Degeneration;   Pigment Epithelial Detachment;   Neovascular Macular Degeneration;   Wet Macular Degeneration
Intervention: Drug: ranibizumab
2 Not yet recruiting Safety & Efficacy Study of the IRay System in Patients With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Conditions: AMD;   Wet AMD;   Age-Related Macular Degeneration;   Wet Age-Related Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
3 Completed Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Maculopathy, Age-Related;   Age-Related Maculopathies;   Age-Related Maculopathy;   Maculopathies, Age-Related
Intervention: Drug: anecortave acetate
4 Recruiting Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Age-Related Maculopathies;   Age-Related Maculopathy;   Maculopathies, Age-Related;   Maculopathy, Age-Related;   Retinal Degeneration;   Retinal Neovascularization;   Gene Therapy;   Therapy, Gene;   Eye Diseases
Intervention: Biological: AAV2-sFLT01
5 Recruiting Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration.
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
6 Not yet recruiting Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
7 Recruiting The Efficacy of Oral Everolimus in Patients With Neovascular Age-Related Macular Degeneration
Conditions: Choroidal Neo-Vascular Age-Onset Macular Degeneration;   Age-Related Macular Degeneration
Interventions: Drug: RAD001;   Drug: Lucentis;   Drug: RAD001 in combination with Lucentis
8 Recruiting A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Conditions: Age Related Macular Degeneration;   Choroidal Neovascular Membrane;   Subfoveal Neovascular Age-Related Macular Degeneration;   Macular Degeneration;   Wet Age-Related Macular Degeneration
Intervention: Drug: Ranibizumab
9 Terminated An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
Conditions: Age Related Macular Degeneration (AMD);   Macular Degeneration;   Choroidal Neovascularization (CNV)
Intervention: Drug: Pegaptanib Sodium 0.3 mg
10 Completed Identification and Treatment of Feeder Vessels in Macular Degeneration
Condition: Macular Degeneration
Interventions: Procedure: Angiography;   Procedure: Laser Treatment
11 Recruiting High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention:
12 Completed Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-Like Macular Dystrophy
Condition: Macular Degeneration
Intervention: Drug: Docosahexaenoic Acid (DHA) Dietary Supplement
13 Withdrawn Combination Therapy for Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: intravitreal bevacizumab and triamcinolone acetonide
14 Completed Fluocinolone Implant to Treat Macular Degeneration
Conditions: Choroidal Neovascularization;   Macular Degeneration
Intervention: Drug: Fluocinolone
15 Completed Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy
Condition: Macular Degeneration
Intervention: Drug: Celecoxib
16 Recruiting A Study of Ranibizumab Administered Monthly or on an As-Needed Basis in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: ranibizumab
17 Completed Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: TAC-PF;   Drug: Triamcinolone Acetonide
18 Completed Oxidative Stress in Patients With Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention:
19 Recruiting Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control
20 Recruiting VEGF-Antagonism and Endothelial Function in Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Other: No treatment

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services